Innovation-Driven
Creative, methodical solutions that accelerate product development across the value chain.

Advancing Science, Delivering Trust
Connecting the dots from API to Finished Formulations, and from manufacturer to customer — with a deliberate focus on Europe, United States and Stringent Regulated markets across the globe.
25+
Years of collective leadership
API → FDF
Full value chain coverage
SRA Markets
Focus on a SRA market, Have Access to EU, US, and Other ROW markets
10+
Pipeline products
Strategic Vision
TriXion Life Sciences was founded by partners with over a quarter-century of collective experience across APIs, DC granules, pellets and finished formulations. That experience is applied to one purpose: making the right connections happen faster.
Creative, methodical solutions that accelerate product development across the value chain.
A robust ecosystem of global partners and domain experts fostering collaborative excellence.
Connecting strategic partners across the pharmaceutical value chain to enhance development.
Expertise Spectrum
Fragmented sourcing creates risk. We manage the complex journey from raw material through to Finished Dosage Forms, so manufacturers gain market access and customers gain supply they can defend in an audit.
Qualified sources with regulated-market dossier readiness.
Directly Compressible granules and Pellets
Oral Solids, Oral Solutions, Topical, Injectables and Differentiated Generics

Global Footprint
Development is concentrated where quality expectations are highest. We partner with PAN-Europe customers and local leaders across the EU and US, and connect them to a robust CDMO/CMO network.
Connecting the Dots
Two clear routes into TriXion, each handled by the business development team that owns that segment.
Sourcing, supply and partnering enquiries for APIs, intermediates, DC granules and pellets.
api.bd@trixionls.comEnquiries for finished formulations, CDMO/CMO partnering and regulated-market supply.
fdf.bd@trixionls.comShare your molecule, dosage form and target markets. We will come back with a defined route to partnership.